Evaluation of PET ligands (+)N‐[11C]ethyl‐3‐piperidyl benzilate and (+)N‐[11C]propyl‐3‐piperidyl benzilate for muscarinic cholinergic receptors: A PET study with microdialysis in comparison with (+)N‐[11C]methyl‐3‐piperidyl benzilate in the conscious monkey brain
- 9 April 2001
- Vol. 40 (3) , 159-169
- https://doi.org/10.1002/syn.1038
Abstract
We developed PET ligands (+)N‐[11C]ethyl‐3‐piperidyl benzilate ([11C](+)3‐EPB) and (+)N‐[11C]propyl‐3‐piperidyl benzilate ([11C](+)3‐PPB) for cerebral muscarinic cholinergic receptors. The distribution and kinetics of the novel ligands were evaluated for comparison with the previously reported ligand (+)N‐[11C]methyl‐3‐piperidyl benzilate ([11C](+)3‐MPB) in the monkey brain (Macaca mulatta) in the conscious state using high‐resolution positron emission tomography (PET). At 60–91 min postinjection, regional distribution patterns of these three ligands were almost identical, and were consistent with the muscarinic receptor density in the brain as previously reported in vitro. However, the time–activity curves of [11C](+)3‐EPB and [11C](+)3‐PPB showed earlier peak times of radioactivity and a faster clearance rate than [11C](+)3‐MPB in cortical regions rich in the receptors. Kinetic analysis using the three‐compartment model with time–activity curves of radioactivity in metabolite‐corrected arterial plasma as input functions revealed that labeling with longer [11C]alkyl chain length induced lower binding potential (BP = k3/k4), consistent with the rank order of affinity of these ligands obtained by an in vitro assay using rat brain slices and [3H]QNB. The cholinesterase inhibitor Aricept administered at doses of 50 and 250 μg/kg increased acetylcholine level in extracellular fluid of the frontal cortex and the binding of [11C](+)3‐PPB with the lowest affinity to the receptors was displaced by the endogenous acetylcholine induced by cholinesterase inhibition, while [11C](+)3‐MPB with the highest affinity was not significantly affected. Taken together, these observations indicate that the increase in [11C]alkyl chain length could alter the kinetic properties of conventional receptor ligands for PET by reducing the affinity to receptors, which might make it possible to assess the interaction between endogenous neurotransmitters and ligand‐receptor binding in vivo as measured by PET. Synapse 40:159–169, 2001.Keywords
This publication has 45 references indexed in Scilit:
- Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysisSynapse, 2000
- Fluorinated benzamide neuroleptics. 1. Radiosynthesis of (S)‐N‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐5‐(2[F‐18]fluoroethyl)‐2‐methoxybenzamide: A potential fluorine‐18 labeled PET radiotracer for dopamine D2 receptorsJournal of Labelled Compounds and Radiopharmaceuticals, 1990
- N-Substituted derivatives of 4-piperidinyl benzilate: Affinities for brain muscarinic acetylcholine receptorsLife Sciences, 1989
- Synthesis of n.c.a.[11C]QNBJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- Routine synthesis of N-[11C-methyl]scopolamine by phosphite mediated reductive methylation with [11C]formaldehydeApplied Radiation and Isotopes, 1988
- The synthesis of 1-11C-labelled ethyl, propyl, butyl and isobutyl iodides and examples of alkylation reactionsInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Studies on Muscarinic Binding Sites in Human Brain Identified with [3H]PirenzepineJournal of Neurochemistry, 1986
- [N‐methyl‐11C]‐scopolamine: Synthesis and distribution in rat brainJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973